Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Aspire Biopharma Holdings Inc

ASBP ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Pharmaceuticals ·

USA Micro Cap Analyst: N/A

Last Close

$8.27

▲ +5.89%

Market Cap $11.60M · Vol 6.35K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$11.60M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

63.76

Momentum

Beta

0.08

vs Market

52W High

$711.96

98.84% below

52W Low

$3.35

147.01% above

Volume

6.35K

Avg 8.45K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

79.90%

Public shares

Shariah Compliance8 STANDARDS

✗ Aspire Biopharma Holdings Inc (ASBP) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does ASBP pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+8.25%

+13.91%

+52.87%

-80.72%

YTD

-94.78%

-98.75%

-99.94%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$6.20K
Net Income	$-24,480,850.00
Revenue Growth (YoY)	N/A
Gross Margin	-1.87%
Operating Margin	-312,016.95%
Net Profit Margin	-394,725.06%
ROE	N/A
ROA · ROIC	-610.00% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	1,271.75
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	1.40M

Technical Indicators

50-Day SMA	$6.76
200-Day SMA	$46.05
RSI (14)	63.76
Beta	0.08
52-Week High	$711.96
52-Week Low	$3.35

Volume Today	6.35K
Avg Daily Volume (30D)	8.45K
Relative Volume	0.75x
Volatility (10D)	68.93
Volatility (30D)	118.88
Free Float	79.90%

Analyst Consensus

N/A

Current Price $8.27

Mean Target N/A

52W Low$3.35 52W High$711.96

Current

Target

$3.35 $711.96

Current Analyst target

· 0 analysts

Identifiers

ExchangeNasdaq

FIGIBBG015STV142

ISINUS7389203057

CountryUnited States of America

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -1.06% JNJ Johnson & Johnson +0.04% ABBV Abbvie Inc +0.48% NVS Novartis AG +1.24% NOVN.S Novartis AG +1.25%

Company Profile

Aspire Biopharma Holdings, Inc. is an early-stage biopharmaceutical company. The Company is a developer of multi-faceted patent-pending drug delivery technology. It is engaged in developing and marketing the disruptive technology for novel sublingual delivery mechanisms for known drugs. Its patent pending delivery system includes components formulated to allow sublingual absorption of drugs into the blood stream, thus by-passing the gastrointestinal tract. Its delivery technology is focused on different active pharmaceutical ingredients (APIs) and other bioactive substances, spanning both small and large molecule therapeutics, nutraceuticals and supplements. Its Sublingual Aspirin Product addresses cardiology emergencies and pain management. Its other products include Melatonin, Vitamins, Erectile Dysfunction Medication, Caffeine Products, and Other Products, which includes anti-nausea products (meclizine and ondansetron), alprazolam, clopidogrel, microdose nicotine, and semaglutide.